Patient number | Age | Genotype | Phenotype | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |  | Allele 1 | Allele 2 | CT | Age of onset | Diameter (mm) | PTA (L) (dB) | PTA (R) (dB) | Thyroid hormone | US scan Of thyroid | ||||
 |  | Nucleotide Change | amino acid change | category | nucleotide change | amino acid change | category |  |  |  |  |  |  |  |
1 | 17 | IVS7-2 | aberrant splicing | pathogenic | IVS7-2 | aberrant splicing | pathogenic | aEVA | 0.7 | 3.28 | 82. | 93 | normal | normal |
2 | 17 | IVS7-2 | aberrant splicing | pathogenic | IVS7-2 | aberrant splicing | pathogenic | EVA | 2 | 3.33 | 103 | 106 | normal | normal |
3 | 9 | IVS7-2 | aberrant splicing | pathogenic | IVS7-2 | aberrant splicing | pathogenic | EVA | 2.5 | 2.73 | 93 | 95 | Total T3 slightly elevated | normal |
4 | 16 | IVS7-2 | aberrant splicing | pathogenic | IVS7-2 | aberrant splicing | pathogenic | EVA | 0 | 2.73 | 97 | 97 | normal | normal |
5 | 10 | IVS7-2 | aberrant splicing | pathogenic | IVS7-2 | aberrant splicing | pathogenic | EVA | 1 | 3.64 | 76 | 93 | normal | normal |
6 | 14 | IVS7-2 | aberrant splicing | pathogenic | IVS7-2 | aberrant splicing | pathogenic | EVA | 2 | 2.73 | 96 | 83 | normal | normal |
7 | 10 | IVS7-2 | aberrant splicing | pathogenic | IVS7-2 | aberrant splicing | pathogenic | EVA | 1 | 2.0 | 88 | 95 | normal | normal |
8 | 8 | IVS7-2 | aberrant splicing | pathogenic | IVS7-2 | aberrant splicing | pathogenic | EVA | 2 | 1.64 | 101 | 95 | normal | normal |
9 | 19 | IVS7-2 | aberrant splicing | pathogenic | 230A>T | K77I | pathogenic | EVA | 4 | 2.22 | 71 | 55 | normal | normal |
10 | 16 | IVS7-2 | aberrant splicing | pathogenic | 1229C>T | bT410M | pathogenic | EVA | 3 | 4.55 | 78 | 77 | normal | normal |
11 | 14 | IVS7-2 | aberrant splicing | pathogenic | 1975G>C | bV659L | pathogenic | EVA | 3 | 4.19 | 95 | 95 | normal | normal |
12 | 13 | IVS7-2 | aberrant splicing | pathogenic | 2168A>G | H723R | pathogenic | EVA | 3.5 | 4.55 | 96 | 85 | normal | normal |
13 | 13 | 2168A>G | H723R | pathogenic | 109G>T | E37X, nonsense mutation | pathogenic | EVA | 0 | 2.89 | 90 | 87 | normal | Cystoid change |
14 | 19 | 2168A>G | H723R | pathogenic | 1229C>T | bT410M | pathogenic | EVA | 1.5 | 2.44 | 107 | 102 | normal | normal |
15 | 17 | 2168A>G | H723R | pathogenic | 2167C>G | H723D | Unclassified variant | EVA | 0.25 | 5.46 | 85 | 100 | normal | normal |
16 | 14 | 1173C>A | S391R | pathogenic | 1229C>T | bT410M | pathogenic | EVA | 0.1 | 3.33 | 95 | 90 | normal | normal |
17 | 10 | 1124A>G | Y375C | Unclassified variant | 1409G>A | R470H | Unclassified variant | Vestibular and cochlear malformation | 0.1 | Â | aNA | NA | NA | NA |
18 | 19 | 1472T>C | I491T | Unclassified variant | Â | Â | Â | EVA and Mondini | 0.6 | 4.44 | 100 | 100 | NA | NA |
19 | 16 | IVS7-2 | aberrant splicing | pathogenic | Â | Â | Â | EVA | 2 | 5.46 | 93 | 92 | Total T3 slightly elevated | normal |
20 | 10 | IVS7-2 | aberrant splicing | pathogenic | Â | Â | Â | EVA | 2 | 2.66 | 76 | 77 | normal | normal |
21 | 17 | IVS7-2 | aberrant splicing | pathogenic | 1905G>A | E635E | Silent variant | aND | 1 | Â | 84 | 107 | NA | NA |
22 | 19 | 1174A>T | N392Y | pathogenic | Â | Â | Â | ND | 0 | Â | 100 | 100 | NA | NA |
23 | 16 | IVS7-2 | aberrant splicing | pathogenic | Â | Â | Â | anl | 1 | Â | 110 | 102 | NA | NA |
24 | 24 | IVS7-2 | aberrant splicing | pathogenic | Â | Â | Â | nl | 1.1 | Â | 100 | 100 | NA | NA |
25 | 19 | 1790T>C | L597S | Unclassified variant | Â | Â | Â | nl | 1.2 | Â | 100 | 100 | NA | NA |
26 | 17 | 1975G>C | bV659L | pathogenic | Â | Â | Â | nl | 0 | Â | 98 | 100 | normal | normal |
27 | 15 | 757A>G | I253V | Unclassified variant | Â | Â | Â | nl | 1 | Â | 110 | 108 | NA | NA |
28 | 17 | 200C>G | T67S | Unclassified variant | Â | Â | Â | nl | 1.3 | Â | 95 | 100 | normal | normal |
29 | 13 | IVS12-6 insT | Intron insertion | Unclassified variant | Â | Â | Â | nl | 1 | Â | 97 | 100 | NA | NA |
30 | 16 | 225C>G | L75L | Silent variant | Â | Â | Â | ND | 0 | Â | 110 | 103 | NA | NA |
31 | 20 | 678T>C | A226A | Silent variant | Â | Â | Â | nl | 1 | Â | 105 | 105 | NA | NA |
32 | 18 | 1905G>A | E635E | Silent variant | Â | Â | Â | nl | 0.7 | Â | 110 | 110 | normal | normal |